Amélie Lothe

6PUBLICATIONS
25CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Child and adolescent developmentPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 22, 2026
Efficacy and safety of fenfluramine in Dravet syndrome: The impact of patient clinical characteristics.

|Aug 03, 2026
Changes in effectiveness and safety in patients with Lennox-Gastaut syndrome transitioning from the fenfluramine randomized controlled trial to open-label extension study.

|Jul 04, 2026
Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness.

|Mar 12, 2025
Long-term safety and effectiveness of fenfluramine in children and adults with Dravet syndrome.

Ingrid E Scheffer, Rima Nabbout, Lieven Lagae

|Jul 20, 2024
Comprehensive scoping review of fenfluramine's role in managing generalized tonic-clonic seizures in developmental and epileptic encephalopathies.

Antonio Gil-Nagel, J Helen Cross, Orrin Devinsky

|Nov 29, 2023
Fenfluramine increases survival and reduces markers of neurodegeneration in a mouse model of Dravet syndrome.

John Cha, Gregory Filatov, Steven J Smith

Pageof 1

Frequent Collaborators

4 joint publications

Orrin Devinsky

4 joint publications

Lieven Lagae

4 joint publications

Kelly Knupp

4 joint publications

Rima Nabbout